Glutamine and protein synthesis -
By keeping your protein intake high and adding a quality glutamine supplement like GL3 may be a way to stimulate protein synthesis rates more effectively and help bust through plateaus in training.
In this study, the added glutamine also elevated plasma glutamine levels. Plasma glutamine is the fuel for optimal function of the immune system and internal organs.
Glutamine supplementation appears to meet the ravenous metabolic demands of internal organs and the immune system allowing the quality proteins such as whey and casein to deliver their amino acids right to muscle cells.
This would stimulate more constant, uninterrupted protein synthesis, and create a more permanent state of anabolism within muscle cells.
com Facebook Twitter. Facebook Twitter. See Also:. Recent Posts How to Use Protein, Carbohydrate, and Creatine Timing For Maximum Gains Creatine Stimulates Muscle Growth by Triggering Satellite Cell Formation Lower Testosterone Leads to Higher Body Fat How to Strive For Excellence 5 Research Proven Strategies For Maximum Muscle Gains.
Search for:. Name: Email Address: Question or Comment: Are you human? time to read: 2 min. Training Building Powerful Pecs. Articles 5 Research-Proven Strategies for Rapid Muscle Mass…. Loading Comments Email Required Name Required Website.
At h, baseline blood and expired air samples were obtained. To collect breath samples, children were asked to breathe through a mouthpiece mounted with a one-way valve and connected to a 5-L rubber bag. At h children received a primed, continuous i.
infusion of L-[1- 13 C]leucine 3 μmol·kg -1 , 3μmol·kg -1 ·h -1 , and L-[2- 15 N]glutamine 8 μmol·kg -1 , 8 μmol·kg -1 ·h -1 for 5 h using a calibrated syringe-pump.
The second study day, 0. Plasma amino acid concentrations were measured at the end of each study day from an arterialized blood sample. Analytical methods. E p ,KIC , E p ,gln , and plasma KIC concentrations were measured by gas chromatography-mass spectrometry 15 , E 13 CO 2 was measured using gas chromatography-isotopic ratio mass spectrometry V.
Isogas, Ipswich, UK. Plasma amino acid concentrations were measured using an amino acid analyzer Beckman, High Performance Analyzer, System Plasma insulin concentrations were determined by RIA Endocrine Science, Calabasas Hills, CA.
Leucine oxidation Ox leu inμmol·kg -1 ·h -1 was calculated as:Equation where VCO 2 is the rate of CO 2 production in mL·min -1 measured by indirect calorimetry, 60 converts min to h, k CO 2 is the fractional recovery of CO 2 in expired air 0.
NOLD in μmol·kg -1 ·h -1 , an index of protein synthesis, was calculated as: Equation. infusate, and i [ 15 N] g ln is the tracer infusion rate μmol·kg -1 ·h -1 18 , During glutamine oral administration, endogenous glutamine rate of appearance in plasma Endo R a ,gln was calculated as:Equation where Inf gln is the rate of oral delivery of L-glutamine i.
Glutamine arising from protein breakdown B gln was calculated as 19 : Equation where 0. Glutamine de novo synthesis D gln was calculated as 19 : Equation. Data are means ± SEM. Comparisons between study days were performed using paired t test.
Substrate concentrations. On the control day, blood urea nitrogen decreased by 0. During glutamine oral administration, blood urea nitrogen increased by 1. Leucine kinetics. Plasma [ 13 C]KIC enrichments, 13 CO 2 enrichments in expired air, and plasma KIC concentrations were at steady state on both study days.
Effect of oral glutamine on whole body leucine kinetics. Results are mean ± SEM; solid bars , oral glutamine administration; open bars , flavored water administration; Ra,leu , leucine release from protein breakdown; Ox,leu , leucine oxidation rate; NOLD , index of whole body protein synthesis; significance of observed differences by paired t test.
Glutamine kinetics. Plasma [ 15 N]glutamine enrichments Fig. Glutamine enrichments in plasma. Each value represents the mean ± 1 SEM of patients measured at each time point.
To our knowledge, the present study is first to demonstrate that oral glutamine administration is associated with an acute decrease in leucine release from protein breakdown in children with DMD.
This suggests that oral glutamine might have a protein-sparing effect in DMD. In addition, oral glutamine administration was associated with a decrease in estimates of glutamine de novo synthesis, suggesting that exogenous glutamine might preserve muscle amino acid stores in DMD.
In boys suffering from DMD, oral glutamine administration was associated with an acute decrease in leucine release from protein breakdown and leucine oxidation rate resulting in no change in nonoxidative leucine disposal, an index of protein synthesis.
The inhibition of protein breakdown observed using stable isotope methodology is strengthened by the concomitant decrease in plasma leucine, lysine, and phenylalanine concentrations, three essential amino acids whose only source in the postabsorptive state is protein degradation.
In the present study as in healthy adults receiving the same dose of enteral glutamine 7 , plasma insulin concentration did not rise significantly, therefore suggesting that decreased protein degradation is not due to insulin.
An inhibitory effect of glutamine on protein breakdown was shown in perfused rat skeletal muscle To date mechanisms involved in the inhibition of protein breakdown in DMD remain unclear. We did not perform leucine kinetics measurements with an isonitrogenous control because at the beginning of the study we did not know whether or not glutamine would have any effect on protein metabolism in DMD.
This kind of experiment is rather cumbersome for children, and including more patients to test the specificity of glutamine's effect on protein metabolism was ethically questionable. Recent studies on nitric oxide synthesis in muscle wasting 21 and onα-tocopherol administration in mdx mice 4 , an animal model of DMD, might provide clues to help in understanding glutamine's effect on protein metabolism in DMD.
Although still debated 22 , an increase in muscle protein breakdown might be the main process leading to muscle mass loss in DMD 23 , The present study as well as animal studies 23 , 25 suggest that protein degradation might be accessible to therapeutic modulation in DMD.
CO 2 recovery values are instrumental for calculating the leucine oxidation rate and nonoxidative leucine disposal calculations. However, CO 2 recovery would not affect the effect of glutamine on whole body protein degradation.
In the present study, we used the values measured previously in healthy adults by our group 7. Similar CO 2 recovery values were obtained in premature infants Therefore, age might not affect CO 2 recovery.
To date, CO 2 recovery has not been measured in patients with DMD. Measuring CO 2 recovery involves a 2-d study with NaHCO 3 i. infusion while giving glutamine or saline enterally. We have shown in a previous study that glutamine does not alter 13 CO 2 recovery in healthy adults 7.
For ethical reasons we did not perform this experiment that would require more patients in a pediatric population. Unlike in healthy adults 7 , acute oral glutamine administration failed to stimulate protein synthesis in children with DMD.
A few hypotheses can be proposed to explain this discrepancy: 1 an increase in muscle protein synthesis may be more difficult to detect in DMD patients than in healthy subjects because of the dramatic reduction in muscle mass that reduces the relative contribution of muscle to whole body protein synthesis 27 ; 2 muscle protein synthesis might be at or near its maximum in DMD and not be further stimulable 25 ; 3 previous study reported low intramuscular glutamine concentration in DMD 10 , 11 , and it might take longer to increase it sufficiently to stimulate protein synthesis; and 4 finally, muscle protein synthesis per se , might be defective.
Specific patterns of protein metabolism have been reported in other studies in DMD patients; unlike in healthy volunteers 28 , 29 prednisone does not increase protein degradation and does improve muscle mass indices and muscle function in DMD Further studies exploring muscle protein metabolism and the adjacent connective tissue that might have a key role in muscle degeneration in DMD 30 are required to help in understanding the present results.
The response of whole body glutamine exchange in plasma in the postabsorptive state and during oral glutamine administration had not been evaluated in DMD.
As in healthy humans 18 , glutamine appearance rate and plasma glutamine concentration doubled during oral glutamine administration. These data thus suggest that oral glutamine is bioavailable in children with DMD.
In addition, oral glutamine administration inhibits endogenous glutamine production through a decrease in estimates of both glutamine de novo synthesis and glutamine release from protein breakdown.
Although the glutamine de novo synthesis rate should be taken with caution because it is a calculated value, these results suggest that glutamine synthetase might be an important regulatory step in glutamine homeostasis. Such a role for glutamine synthetase is also suggested in vitro 31 and in humans 32 , Because glutamine is synthesized from other amino acids, e.
branched chain amino acids 34 , the decrease in glutamine de novo synthesis may be considered a protein-saving mechanism because it saves precursor amino acid stores.
This might, in turn, help decrease protein degradation. In summary, acute oral glutamine administration might have an acute protein-sparing effect in DMD resulting from a decrease in protein degradation. It remains to be determined whether long-term oral glutamine administration will have beneficial effects on muscle mass and function in DMD.
Hoffman E, Fischbeck K, Brown R, Johnson M, Medori R, Loike J, Harris J, Waterston R Characterization of dystrophin in muscle biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med : — Article CAS Google Scholar.
Mendell J, Kissel J, Amato A, King W, Signore L, Prior T, Sahenk Z, Benson S, McAndrew P, Rice R, Nagaraja H, Stephens R, Lantry L, Morris G, Burghes A Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
Hankard R, Gottrand F, Turck D, Carpentier A, Romon M, Farriaux J Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res 40 : 1—5. Article Google Scholar. Hübner C, Lehr H-A, Bodlaj R, Finckh B, Oexle K, Marklund S, Freudenberg K, Kontush A, Speer A, Terwolbeck K, Voit T, Kohlschütter A Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy.
Pediatr Res 40 : — Bergström J, Fürst P, Norée L, Vinnars E Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 36 : — Jepson M, Bates P, Broadbent P, Pell J, Millward D Relationship between glutamine concentration and protein synthesis in rat skeletal muscle.
Am J Physiol :E—E CAS Google Scholar. Hankard R, Haymond M, Darmaun D Effect of glutamine on leucine metabolism in humans. Vinnars E, Bergstöm J, Fürst P Influence of the post operative state on the intracellular free amino acids in human muscle tissue.
Ann Surg : — Wernerman J, Hammarqvist F, Vinnars E α-Ketoglutarate and postoperative muscle catabolism. Lancet : — Rennie M Leucine metabolism in skeletal muscle and whole body in normal men and patients with a muscle disease. In: Serratice, G, Denvelle C, Pellicier J eds Neuromuscular Diseases.
Raven Press , New York, pp 37— Google Scholar. Rennie M, MacLennan P, Hundal H, Weryk B, Smith K, Taylor P, Egan C, Watt P Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover.
Metabolism 38 : 47— Rennie M, Edwards R, Millward D, Wolman S, Halliday D, Matthews D Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature : — Matthews D, Motil K, Rohrbaugh D, Burke J, Young V, Bier D Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1- 13 C]leucine.
CAS PubMed Google Scholar. Griffiths R, Edwards R A new chart for weight control in Duchenne muscular dystrophy. Arch Dis Child 63 : — Matthews D, Schwartz H, Yang R, Motil K, Young V, Bier D Relationship of plasma leucine and α-ketoisocaproate during a L-[1- 13 C]leucine infusion in man: a tracer method for measuring human intracellular leucine tracer enrichment.
Metabolism 31 : — Darmaun D, Manary M, Matthews D A method for measuring both glutamine and glutamate levels and stable isotope enrichments. Anal Biochem : 97— Horber F, Horber-Feyder C, Krayer S, Schwenk W, Haymond M Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis.
Hankard R, Darmaun D, Sager B, D'Amore B, Parsons R, Haymond M Response of glutamine metabolism to exogenous glutamine in humans.
Darmaun D, Matthews D, Bier D Glutamine and glutamate kinetics in humans. MacLennan P, Smith K, Weryk B, Watt P, Rennie M Inhibition of protein breakdown by glutamine in perfused rat skeletal muscle. FEBS Lett : — Buck M, Chojkier M Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.
EMBO J 15 : — Griggs RC, Rennie MJ Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation?. Ann Neurol 13 : — Li J Protein synthesis and degradation in skeletal muscle of normal and dystrophic hamsters.
Turner P, Westwood T, Regen C, Steinhardt R Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Zdanowicz M, Slonim A, Bilaniuk I, O'Connor M, Moyse J, Teichberg S High protein diet has beneficial effects in murine muscular dystrophy.
J Nutr : — Van Aerde J, Sauer P, Pencharz P, Canagarayar U, Beesley J, Smith J, Swyer P The effect of energy intake on the recovery of 13 CO2 in the parenterally fed neonate during a 4-hour primed constant infusion of NaH 13 CO3.
Pediatr Res 19 : — Rifai Z, Welle S, Moxley R, Lorenson M, Griggs R Effect of prednisone on protein metabolism in Duchenne dystrophy. Am J Physiol :E67—E Beaufrere B, Horber F, Schwenk F, Marsh H, Matthews D, Gerich J, Haymond M Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans.
Darmaun D, Matthews D, Bier D Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Morea M, Cornelio F, Morandi L, Mantegazza R Expression of transforming growth factor-β1 in dystrophic patient muscles correlates with fibrosis.
J Clin Invest 96 : — Smith R, Larson S, Stred S, Durschlag R Regulation of glutamine synthetase and glutaminase activities in cultured skeletal muscle cells.
Glufamine you for Natural fat burner supplements nature. Prorein are using a browser version with limited support for Gluamine. To obtain the best Low GI meals, we Gllutamine you use a more up to date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. As knowledge of cell metabolism has advanced, glutamine has been considered an important amino acid that supplies carbon and nitrogen to fuel biosynthesis.
0 thoughts on “Glutamine and protein synthesis”